| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5173(98)00398-6 |
| P8608 | Fatcat ID | release_5lyijq5htng5jnul7zlqyibita |
| P698 | PubMed publication ID | 10370197 |
| P2093 | author name string | Nieminen MM | |
| Saari M | |||
| Turjanmaa VM | |||
| Koskinen MO | |||
| Vidgren MT | |||
| P2860 | cites work | Methacholine bronchial challenge using a dosimeter with controlled tidal breathing | Q36190757 |
| Surfactant treatment for premature babies--a review of clinical trials | Q37711816 | ||
| Metabolism and turnover of lung surfactant | Q39664788 | ||
| Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. | Q52760720 | ||
| Prevalence of asthma in young cross-country skiers in central Scandinavia: differences between Norway and Sweden. | Q53153622 | ||
| Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. | Q53950836 | ||
| Surfactant replacement therapy in respiratory distress syndrome. Meta-analysis of clinical trials of single-dose surfactant extracts | Q67897256 | ||
| Small particle aerosols of enviroxime-containing liposomes | Q68035735 | ||
| Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung | Q69681435 | ||
| Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers | Q70141374 | ||
| Pulmonary effects of chronic exposure to liposome aerosols in mice | Q70577776 | ||
| Obstructive symptoms in athletes: is it asthma and what to do about it? | Q71655837 | ||
| Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol | Q72692608 | ||
| Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety | Q73092729 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. | |
| P478 | volume | 181 |
| Q34508730 | (99m)Tc-labeled therapeutic inhaled amikacin loaded liposomes |
| Q44193671 | A facile method of delivery of liposomes by nebulization |
| Q37360645 | A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: a technical note |
| Q37565681 | Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties |
| Q38112183 | Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications |
| Q44541470 | Encapsulating protein into preformed liposomes by ethanol-destabilized method |
| Q51171665 | Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. |
| Q51085961 | Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. |
| Q39339379 | Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules |
| Q30723752 | Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes |
| Q40792009 | Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion |
| Q37360927 | Liposomal dry powders as aerosols for pulmonary delivery of proteins |
| Q38126942 | Liposomal formulations for inhalation |
| Q33890202 | Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries |
| Q38759181 | Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications |
| Q42589345 | Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery |
| Q92564117 | Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine |
| Q59089495 | Phospholipids in pulmonary drug delivery |
| Q38298133 | Pulmonary delivery of anti-inflammatory agents |
| Q35583186 | Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications |
| Q44947668 | Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity |
| Q37978509 | Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery |
| Q35872560 | Ultrastructural and Immunohistochemical Studies on Uptake and Distribution of FITC-Conjugated PLGA Nanoparticles Administered Intratracheally in Rats |
| Q47203536 | pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity. |
Search more.